Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Semaglutide for Weight Loss: What the SURMOUNT-5 Results Mean for Northwest Louisiana Patients For the first time, a major clinical trial put tirzepatide (Mounjaro/Zepbound) and semaglutide (Ozempic/Wegovy) head to head in people with obesity who do not have diabetes, and the results landed in the New England Journal of Medicine in May 2025.[1] The short answer: tirzepatide produced significantly more weight loss
TD: Writing original draft, Writing review & editing
High Fibre ContentAids digestive health, improves digestion, and helps maintain a healthy weight
Discard any pen thats been frozen, exposed to high heat, or open for more than 56 days
Mounjaro is FDA approved for Type 2 diabetes but is prescribed off-label (for a non-FDA-approved use) for weight loss
Dehydration from alcohol use combined with GLP-1-induced gastrointestinal side effects could exacerbate electrolyte imbalances and potentially lead to acute kidney injury
